News & Blog
Welcome to the Atelerix News & Blog - warm takes on keeping cells happy without the cold, with company updates & research insights (no frostbite required).
Featured articles
From Lab to Market: Recent Advances and Commercialisation of Organoid Technologies
By Sophie Reay Organoids are three-dimensional (3D) tissue cultures derived from stem cells that self-organise into structures that closely […]
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion Industry-leaders Sunil Shah (CEO, o2h […]
Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone […]
Atelerix at WORD+2026: A Celebration of Innovation in Organoids and Organ-on-a-Chip Research
Earlier this month, the Atelerix team had the pleasure of attending WORD+2026, the 4th Annual World Organoid and Organ-on-a-Chip Research […]
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech […]
Atelerix and Labskin partner to enable long-distance transport of advanced in vitro skin models
Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation Joint […]
Atelerix at ELRIG Drug Discovery 2025: Enabling the Future of Cell Research
The Atelerix team were delighted to take part in ELRIG Drug Discovery 2025, held at the ACC in Liverpool on […]
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetration New distribution channels to […]
Spotlight on Researchers Using Organoids in Disease Modelling
Organoids have rapidly emerged as one of the most powerful tools in biomedical research. These three-dimensional cellular systems, derived from […]
Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical […]
Overcoming Organoid Preservation Challenges in CRO Workflows
Abstract Contract Research Organisations (CROs) are increasingly adopting organoid models for drug discovery, toxicology, and preclinical testing. These three-dimensional cellular […]
From Lab to Market: Recent Advances and Commercialisation of Organoid Technologies
By Sophie Reay Organoids are three-dimensional (3D) tissue cultures derived from stem cells that self-organise into structures that closely […]
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion Industry-leaders Sunil Shah (CEO, o2h […]
Mini Organs, Major Impact: How Organoids Are Redefining Drug Development & Personalised Medicine
By Sophie Reay Organoids are miniature, three-dimensional (3D) tissue cultures that mimic the structure and function of specific organs. They […]
Grant Writing That Stands Out: How Ambient Cell Preservation Can Strengthen Your Application
Securing research funding is a competitive process. Review panels look for more than just sound science – they’re also seeking […]
Rise in the use of organoids to replace animal models: the issue with storage and shipment
By Sophie Reay, Historically, preclinical testing on animal models formed a critical step in the drug discovery and development pipeline, […]
Transforming mRNA Vaccine Distribution: How Atelerix’s CytoStor™ Could Eliminate the Need for the Ultracold Chain
As the global biotechnology sector works to extend the reach of life-saving mRNA vaccines, a persistent challenge remains: the carbon-intensive, […]
Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone […]
